Literature DB >> 10607225

Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication.

S O Cameron1, K S Wilson, T Good, J McMenamin, B McCarron, A Pithie, R Fox.   

Abstract

Hepatitis C surveillance has been restricted owing to the lack of a sensitive antibody assay for saliva. The aim of our study was to develop and evaluate a screening assay for hepatitis C antibody in saliva specimens. Serum/saliva pairs were collected from 115 hepatitis C-positive patients. A modified hepatitis C antibody assay for saliva was developed and linked to testing carried out in the diagnostic laboratory. Correlation between the presence of antibody in serum and in saliva was poor (100% vs 85%). However, of 98 patients who were saliva antibody positive, 96 (98%) were also serum hepatitis C RNA positive and two (2%) were serum hepatitis C RNA negative. Hence, the correlation between a positive salivary antibody test and the serum hepatitis C RNA status of intravenous drug users suggests that this test could be used as a surrogate marker for hepatitis C viraemia in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10607225     DOI: 10.1046/j.1365-2893.1999.00142.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

Authors:  K M Roy; S J Hutchinson; S Wadd; A Taylor; S O Cameron; S Burns; P Molyneaux; P G McIntyre; D J Goldberg
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

3.  Accuracy of rapid oral HCV diagnostic test among a Saudi sample.

Authors:  Suzan Ibrahim; Safia Ali Al Attas; Ghada Anwar Mansour; Soliman Ouda; Hind Fallatah
Journal:  Clin Oral Investig       Date:  2014-05-21       Impact factor: 3.573

4.  Recognition of multiple classes of hepatitis C antibodies increases detection sensitivity in oral fluid.

Authors:  J F Zmuda; B Wagoneer; L Liotta; G Whiteley
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

5.  Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum.

Authors:  L Cock De; V Hutse; R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

6.  Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen.

Authors:  Christine L Moe; Arnie Sair; Lisa Lindesmith; Mary K Estes; Lee-Ann Jaykus
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

7.  Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.

Authors:  P De; E Roy; J-F Boivin; J Cox; C Morissette
Journal:  J Viral Hepat       Date:  2008-01-20       Impact factor: 3.728

8.  Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.

Authors:  V González; E Martró; C Folch; A Esteve; L Matas; A Montoliu; J R Grífols; F Bolao; C Tural; R Muga; J V Parry; V Ausina; J Casabona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-20       Impact factor: 3.267

9.  Detection of Hepatitis C Virus RNA in Blood and Saliva of Transfusion-Dependent Thalassemia Patients Diagnosed with Hepatitis C.

Authors:  Behzad Hooshmand; Seyed Moayed Alavian; Farnaz Kouhestani; Maryam Firouzmandi; Saeed Reza Motamedian
Journal:  Contemp Clin Dent       Date:  2018 Jan-Mar

10.  Prevalence and determinants of hepatitis C virus infection among female drug injecting sex workers in Glasgow.

Authors:  Avril Taylor; Sharon J Hutchinson; Gail Gilchrist; Sheila Cameron; Susan Carr; David J Goldberg
Journal:  Harm Reduct J       Date:  2008-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.